Palo Alto Investors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.7M Sell
685,182
-61,074
-8% -$3.56M 5.92% 4
2025
Q4
$44.3M Sell
746,256
-7,751
-1% -$422K 6.17% 5
2025
Q3
$40.8M Sell
754,007
-86,463
-10% -$4.94M 7.56% 5
2025
Q2
$46.2M Sell
840,470
-150,737
-15% -$8.88M 9.83% 3
2025
Q1
$70.1M Sell
991,207
-76,059
-7% -$5.12M 13.34% 2
2024
Q4
$70.2M Sell
1,067,266
-22,790
-2% -$1.53M 10.87% 3
2024
Q3
$76.6M Sell
1,090,056
-40,111
-4% -$3.35M 9.95% 3
2024
Q2
$93M Sell
1,130,167
-4,402
-0.4% -$366K 10.78% 2
2024
Q1
$99.1M Sell
1,134,569
-366,180
-24% -$32.8M 11.18% 3
2023
Q4
$145M Sell
1,500,749
-330,286
-18% -$29.2M 13.04% 3
2023
Q3
$162M Hold
1,831,035
15.33% 1
2023
Q2
$159M Hold
1,831,035
12.82% 1
2023
Q1
$178M Sell
1,831,035
-54,776
-3% -$5.68M 14.75% 1
2022
Q4
$195M Sell
1,885,811
-90,454
-5% -$8.49M 16.64% 1
2022
Q3
$168M Sell
1,976,265
-85,108
-4% -$7.58M 13.25% 1
2022
Q2
$171M Sell
2,061,373
-78,241
-4% -$6.23M 14.89% 1
2022
Q1
$165M Sell
2,139,614
-73,336
-3% -$6.14M 12.75% 1
2021
Q4
$196M Hold
2,212,950
12.49% 1
2021
Q3
$171M Hold
2,212,950
10.32% 2
2021
Q2
$185M Buy
2,212,950
+7,200
+0.3% +$571K 10.18% 2
2021
Q1
$167M Buy
2,205,750
+50,700
+2% +$4.14M 9.49% 4
2020
Q4
$189M Buy
2,155,050
+422,500
+24% +$33.5M 9.91% 3
2020
Q3
$132M Buy
1,732,550
+326,600
+23% +$33M 7.23% 5
2020
Q2
$173M Sell
1,405,950
-138,213
-9% -$13.7M 10.41% 3
2020
Q1
$130M Sell
1,544,163
-476,973
-24% -$41.1M 10.93% 1
2019
Q4
$171M Sell
2,021,136
-188,368
-9% -$14.2M 9.41% 1
2019
Q3
$149M Sell
2,209,504
-396,981
-15% -$30.6M 9.92% 1
2019
Q2
$223M Sell
2,606,485
-35,000
-1% -$2.99M 10.85% 1
2019
Q1
$235M Buy
2,641,485
+81,752
+3% +$7.58M 9.79% 1
2018
Q4
$218M Buy
2,559,733
+10,302
+0.4% +$980K 11.6% 2
2018
Q3
$247M Hold
2,549,431
9.99% 2
2018
Q2
$240M Buy
2,549,431
+3,949
+0.2% +$346K 9.6% 2
2018
Q1
$206M Buy
2,545,482
+47,676
+2% +$4.09M 8.82% 3
2017
Q4
$223M Buy
2,497,806
+59,287
+2% +$5.16M 9.59% 4
2017
Q3
$227M Buy
2,438,519
+53,800
+2% +$4.75M 9.56% 3
2017
Q2
$217M Buy
2,384,719
+2,100
+0.1% +$191K 10.11% 4
2017
Q1
$209M Buy
2,382,619
+422,400
+22% +$37.6M 9.89% 4
2016
Q4
$162M Buy
1,960,219
+169,320
+9% +$14.6M 9.26% 4
2016
Q3
$166M Buy
1,790,899
+53,500
+3% +$5.04M 9.62% 3
2016
Q2
$135M Buy
1,737,399
+397,052
+30% +$33.8M 10.21% 3
2016
Q1
$111M Buy
1,340,347
+3,500
+0.3% +$285K 8.58% 4
2015
Q4
$140M Sell
1,336,847
-329,645
-20% -$34.4M 7.79% 4
2015
Q3
$176M Buy
1,666,492
+6,400
+0.4% +$855K 8.44% 5
2015
Q2
$227M Buy
1,660,092
+10,300
+0.6% +$1.28M 10.1% 3
2015
Q1
$206M Buy
1,649,792
+347,595
+27% +$36.8M 10.16% 2
2014
Q4
$118M Buy
1,302,197
+37,800
+3% +$3.14M 6.91% 5
2014
Q3
$91.2M Buy
1,264,397
+348,810
+38% +$22.9M 6.82% 4
2014
Q2
$57M Buy
915,587
+169,900
+23% +$10.3M 4.24% 6
2014
Q1
$50.9M Buy
745,687
+4,600
+0.6% +$339K 4.2% 9
2013
Q4
$52.1M Buy
741,087
+176,800
+31% +$12M 4.86% 8
2013
Q3
$40.7M Sell
564,287
-222,832
-28% -$14.8M 4.27% 10
2013
Q2
$43.9M Buy
+787,119
New +$49.1M 5.18% 7

Other funds holding BMRN